Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Acerus Pharmaceuticals Corp.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRhinitis
Indication DetailsTreat seasonal and perennial allergic rhinitis (SAR and PAR)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today